Description

Liptamed-M 50/500 is a combination oral antidiabetic medicine used in the treatment of type 2 diabetes mellitus, particularly in patients whose blood sugar levels are not adequately controlled with a single medication. It contains vildagliptin, which enhances insulin secretion by inhibiting the DPP-4 enzyme, and metformin, which reduces glucose production in the liver and improves insulin sensitivity in the body. Together, these two components help achieve better glycemic control by lowering fasting and post-meal blood sugar levels. The medication is typically taken with meals to reduce gastrointestinal side effects, and the dosage is determined by a healthcare professional based on the patient’s condition. Common side effects may include nausea, diarrhea, headache, or stomach discomfort, especially at the start of treatment. Regular monitoring of blood glucose levels is important while using this medicine, and it should be taken consistently along with proper diet and exercise. Patients should consult their doctor before use, particularly if they have kidney, liver, or heart conditions.